Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 13.45
-0.35 (-2.54%)
May 30, 2025, 3:00 PM CST
SHA:603739 Revenue
Qingdao Vland Biotech INC. had revenue of 310.20M CNY in the quarter ending March 31, 2025, with 8.16% growth. This brings the company's revenue in the last twelve months to 1.34B, up 7.27% year-over-year. In the year 2024, Qingdao Vland Biotech INC. had annual revenue of 1.32B with 10.16% growth.
Revenue (ttm)
1.34B
Revenue Growth
+7.27%
P/S Ratio
2.53
Revenue / Employee
875.68K
Employees
1,535
Market Cap
3.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.32B | 121.86M | 10.16% |
| Dec 31, 2023 | 1.20B | 35.74M | 3.07% |
| Dec 31, 2022 | 1.16B | 12.34M | 1.07% |
| Dec 31, 2021 | 1.15B | 190.57M | 19.85% |
| Dec 31, 2020 | 960.25M | 113.47M | 13.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |